Biblio

Author Title [ Type

] Year

Filters: Author is Issaragrisil, Surapol [Clear All Filters]

Journal Article

Potirat P, Wattanapanitch M, Viprakasit V, Kheolamai P, Issaragrisil S. Stem Cell Res. 2018;34:101344.

Poohadsuan J, O'Doherty GA, Owattanapanich W, Kungwankiattichai S, Rojanasakul Y, Issaragrisil S, Luanpitpong S. Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status. Cell Commun Signal. 2023;21(1):283.

Khampang S, Jiamvoraphong N, Laowtammathron C, Lorthongpanich C, Klaihmon P, Srisook P, Kang X, Luanpitpong S, U-Pratya Y, Issaragrisil S. CRISPR/Cas9 mediated approach to generate YAP-depleted human embryonic stem cell line (MUSIe002-A-1). Stem Cell Res. 2022;66:102990.

Laowtammathron C, Chingsuwanrote P, Choavaratana R, Phornwilardsiri S, Sitthirit K, Kaewjunun C, Makemaharn O, Terbto P, Waeteekul S, Lorthongpanich C, et al. Derivation of human embryonic stem cell line MUSIe001-A from an embryo with homozygous α-thalassemia (SEA deletion). Stem Cell Res. 2020;43:101695.

Wattanapanitch M, Klincumhom N, Potirat P, Amornpisutt R, Lorthongpanich C, U-Pratya Y, Laowtammathron C, Kheolamai P, Poungvarin N, Issaragrisil S. Dual Small-Molecule Targeting of SMAD Signaling Stimulates Human Induced Pluripotent Stem Cells toward Neural Lineages. PLoS One. 2014;9(9):e106952.

Klaihmon P, Luanpitpong S, Lorthongpanich C, Laowtammathron C, Waeteekul S, Terbto P, Issaragrisil S. Episomal vector reprogramming of human umbilical cord blood natural killer cells to an induced pluripotent stem cell line MUSIi013-A. Stem Cell Res. 2021;55:102472.

Potirat P, Wattanapanitch M, Kheolamai P, Issaragrisil S. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors. Stem Cell Res. 2018;32:43-46.

Lorthongpanich C, Laowtammathron C, Jiamvoraphong N, Srisook P, Chingsuwanrote P, Klaihmon P, Waeteekul S, U-Pratya Y, Issaragrisil S. Generation of a serine/threonine-protein kinase LATS1 gene-edited iPSC MUSIi012-A-3. Stem Cell Res. 2020;48:101950.

Klaihmon P, Lorthongpanich C, Kheolamai P, Saisaard W, Issaragrisil S. Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib. Sci Rep. 2024;14(1):3993.

Samart P, Palliyage GHeenatigal, Issaragrisil S, Luanpitpong S, Rojanasakul Y. Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transition. Cell Biosci. 2023;13(1):205.

Kunacheewa C, Owattanapanish W, Jirabanditsakul C, Issaragrisil S. Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations. Cell Transplant. 2020;29:963689720965900.

Laowtammathron C, Lorthongpanich C, Jiamvoraphong N, Srisook P, Klaihmon P, Kheolamai P, Luanpitpong S, Issaragrisil S. Role of YAP in hematopoietic differentiation and erythroid lineage specification of human-induced pluripotent stem cells. Stem Cell Res Ther. 2023;14(1):279.

Lorthongpanich C, Laowtammathron C, Jiamvoraphong N, Srisook P, Chingsuwanrote P, Klaihmon P, Damkham N, Terbto P, Waeteekul S, U-Pratya Y, et al. YAP-depleted iPSC MUSIi012-A-2 maintained all normal stem cell characteristics. Stem Cell Res. 2020;43:101723.